Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D6TB
|
||||
| Former ID |
DNC008317
|
||||
| Drug Name |
1-(oxazol-2-yl)-4-(piperidin-4-yl)butan-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529327] | ||
| Formula |
C12H18N2O2
|
||||
| Canonical SMILES |
C1CNCCC1CCCC(=O)C2=NC=CO2
|
||||
| InChI |
1S/C12H18N2O2/c15-11(12-14-8-9-16-12)3-1-2-10-4-6-13-7-5-10/h8-10,13H,1-7H2
|
||||
| InChIKey |
PKVYQZQOXHRPTR-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529327] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||